Disulfide-Linked Compound Nanoparticles for Tumor-Selective SN-38 Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing carrier-free nano-drugs do not effectively enable drug release specifically in tumor cells, lacking surfactants and efficient targeting mechanisms.
Innovation Solution
A compound represented by General Formula (1) or its salt, with specific alkyl and alkylene groups, is used to form nanoparticles that release the active ingredient SN-38 selectively in tumor cells due to higher glutathione concentrations, utilizing a method involving injection of a water-miscible organic solvent solution into water.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a carrier-free nano-drug is produced using existing top-down or bottom-up methods, then the nanoparticle can be formed without surfactants, but the drug cannot be released specifically in tumor cells
Solution Approach 1:
The nanoparticle incorporates a disulfide bond-containing linker with specific local chemical properties that respond to the high glutathione concentration environment within tumor cells. This local chemical characteristic enables selective drug release only in the tumor cell interior where glutathione levels are elevated, while maintaining stability in normal cells with lower glutathione concentrations.
Solution Approach 2:
The invention exploits the parameter difference of glutathione concentration between tumor cells (high) and normal cells (low) to achieve selective drug release. The disulfide bond in the linker undergoes reduction cleavage specifically under the high glutathione conditions inside tumor cells, changing the chemical state of the drug-nanoparticle complex to release the active ingredient selectively at the target site.
2Reliability
If the compound is designed for tumor cell targeting, then drug release occurs specifically in tumor cells, but rapid release in normal cells must be avoided
Solution Approach 1:
The disulfide bond linker provides different stability characteristics in different biological environments: it remains stable in the low-glutathione environment of normal cells (maintaining drug stability) but undergoes reduction in the high-glutathione environment of tumor cells (enabling selective release). This spatially differentiated stability resolves the contradiction between selective release and drug stability.
3Device complexity
If nanoparticles are formed without surfactants, then the structure is simplified, but the ability to control drug release is reduced
Solution Approach 1:
The invention extracts and removes the surfactant component from the nanoparticle formulation, simplifying the overall structure. Instead of using surfactants for stabilization and control, the design relies on the intrinsic properties of the disulfide bond-containing linker molecule itself to provide both structural integrity and controlled release functionality, achieving simplification without sacrificing control capability.
Solution Approach 2:
The disulfide bond-containing linker serves multiple functions simultaneously: it acts as a connecting bridge between the nanoparticle core and the active ingredient, provides structural stabilization to the nanoparticle, and enables controlled drug release through glutathione-induced reduction. This multi-functionality compensates for the removal of surfactants while maintaining controlled release capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound or its salt, when formulated into nanoparticles, allows for stable transport and controlled release of SN-38 in tumor cells, avoiding rapid release in normal cells and providing a sustained drug delivery system.
Implementation Method 1
nanoparticles that release the active ingredient SN-38 selectively in tumor cells due to higher glutathione concentrations
Implementation Method 2
a method involving injection of a water-miscible organic solvent solution into water
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
A compound represented by General Formula (1) or a salt thereof, in which each of R1 and R2 independently represents an alkyl group having 1 to 4 carbon atoms, R1 and R2 may be bonded to each other to form a ring together with a carbon atom to which R1 and R2 are bonded, and each R3 independently represents an alkylene group having 1 to 4 carbon atoms; nanoparticles containing the compound or a salt thereof; a medicine containing the compound or a salt thereof; and a method for producing nanoparticles, including a step of injecting a water-miscible organic solvent solution of the compound or a salt thereof into water are provided.